Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.9244
-0.0445 (-4.59%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9480
+0.0236 (2.55%)
After-hours: Jun 18, 2026, 7:58 PM EDT
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or -16.36% compared to the previous year.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$10,957
Profits / Employee
-$517,484
Market Cap
205.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% | 184 | 0 |
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Coherus Oncology | 145 |
| Voyager Therapeutics | 141 |
| Adagene | 128 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
| Protara Therapeutics | 46 |
| Whitehawk Therapeutics | 29 |
HUMA News
- 1 day ago - Humacyte price target lowered to $1.25 from $1.50 at TD Cowen - TheFly
- 2 days ago - Humacyte Slides: Corporate presentation - Filings
- 3 days ago - Humacyte Transcript: Study result - Transcripts
- 3 days ago - Humacyte Press release: Study result - Filings
- 3 days ago - Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting - GlobeNewsWire
- 7 days ago - Humacyte price target raised to $4 from $3 at H.C. Wainwright - TheFly
- 8 days ago - Humacyte 47.62M share Spot Secondary priced at $1.05 - TheFly
- 8 days ago - Humacyte, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire